These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 20561028

  • 21. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA, Piqueras L, Bishop-Bailey D.
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [Abstract] [Full Text] [Related]

  • 22. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 23. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?
    Denning GM, Stoll LL.
    Pediatr Pulmonol; 2006 Jan; 41(1):23-34. PubMed ID: 16267824
    [Abstract] [Full Text] [Related]

  • 24. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C, Tsantili-Kakoulidou A, Theocharis S.
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [Abstract] [Full Text] [Related]

  • 25. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A, Wu L, Wang R, de Champlain J.
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [Abstract] [Full Text] [Related]

  • 26. Novel Histone Deacetylase Inhibitor Modulates Cardiac Peroxisome Proliferator-Activated Receptors and Inflammatory Cytokines in Heart Failure.
    Lkhagva B, Lin YK, Kao YH, Chazo TF, Chung CC, Chen SA, Chen YJ.
    Pharmacology; 2015 Apr; 96(3-4):184-91. PubMed ID: 26304494
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.
    Yamagishi S, Ogasawara S, Mizukami H, Yajima N, Wada R, Sugawara A, Yagihashi S.
    J Neurochem; 2008 Jan; 104(2):491-9. PubMed ID: 17995925
    [Abstract] [Full Text] [Related]

  • 29. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T, Miyauchi T, Sakai S, Takanashi M, Irukayama-Tomobe Y, Yamaguchi I.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1481-8. PubMed ID: 15093887
    [Abstract] [Full Text] [Related]

  • 30. Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.
    Mori Y, Hirano T, Nagashima M, Shiraishi Y, Fukui T, Adachi M.
    Metabolism; 2007 Dec 21; 56(12):1714-8. PubMed ID: 17998026
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.
    Lee BC, Lee HJ, Chung JH.
    Neurosci Lett; 2006 Dec 20; 410(2):141-5. PubMed ID: 17084528
    [Abstract] [Full Text] [Related]

  • 34. Peroxisome proliferator-activated receptors (PPARs) and their agonists for hypertension and heart failure: are the reagents beneficial or harmful?
    Chen R, Liang F, Moriya J, Yamakawa J, Takahashi T, Shen L, Kanda T.
    Int J Cardiol; 2008 Nov 12; 130(2):131-9. PubMed ID: 18582964
    [Abstract] [Full Text] [Related]

  • 35. Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat.
    Steinmetz M, Quentin T, Poppe A, Paul T, Jux C.
    Basic Res Cardiol; 2005 May 12; 100(3):263-9. PubMed ID: 15754086
    [Abstract] [Full Text] [Related]

  • 36. Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator-activated receptors beta/delta and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain.
    Glatz T, Stöck I, Nguyen-Ngoc M, Gohlke P, Herdegen T, Culman J, Zhao Y.
    J Hypertens; 2010 Jul 12; 28(7):1488-97. PubMed ID: 20410836
    [Abstract] [Full Text] [Related]

  • 37. PPARs modulate cardiac metabolism and mitochondrial function in diabetes.
    Lee TW, Bai KJ, Lee TI, Chao TF, Kao YH, Chen YJ.
    J Biomed Sci; 2017 Jan 10; 24(1):5. PubMed ID: 28069019
    [Abstract] [Full Text] [Related]

  • 38. Effects of probucol on hepatic tumor necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 expression in diabetic rats.
    Zhang X, Li Z, Liu D, Xu X, Shen W, Mei Z.
    J Gastroenterol Hepatol; 2009 Jun 10; 24(6):1058-63. PubMed ID: 19220660
    [Abstract] [Full Text] [Related]

  • 39. Expression and function of peroxisome proliferator-activated receptors in human melanocytes.
    Kang HY, Chung E, Lee M, Cho Y, Kang WH.
    Br J Dermatol; 2004 Mar 10; 150(3):462-8. PubMed ID: 15030328
    [Abstract] [Full Text] [Related]

  • 40. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
    Jozefowicz E, Brisson H, Rozenberg S, Mebazaa A, Gelé P, Callebert J, Lebuffe G, Vallet B, Bordet R, Tavernier B.
    Crit Care Med; 2007 Mar 10; 35(3):856-63. PubMed ID: 17255874
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.